Condition
Verruca
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
75%
3 of 4 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03487549Phase 2Completed
Cantharidin and Occlusion in Verruca Epithelium
NCT04738734Not ApplicableCompleted
CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts
NCT04554394Not ApplicableCompleted
CellFX System for the Treatment of Cutaneous Non-Genital Warts
NCT01536834Not ApplicableCompletedPrimary
Safety & Performance Study of Verruca Treatment Device
Showing all 4 trials